Live Analyst Rating Changes 10175 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Frank Takkinen
LS
Frank Takkinen
Lake Street
Wall Street Analyst
★★★★★
#149
on 13Foresight · ranked by our own returns
40%
Success Rate
-4.5%
Average Return
21 of 52 calls profitable · -223.5% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 40% of Frank Takkinen's ratings turned a profit when each position was held for 1 year — averaging -4.5% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

228 Buy 12 Hold 0 Sell
Frank's Stock Coverage 41 ratings · 2026-07-20
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
ELUT
Elutia
 Jul 17, 2026 BUY Strong Buy
+752.6% avg upside
5 analysts
$5.00
426.25% Upside
 ·
ANGO
AngioDynamics
 Jul 14, 2026 BUY Strong Buy
+31.5% avg upside
9 analysts
$24.00
77.57% Upside
 +3.9%
RCEL
Avita Medical
 Jul 06, 2026 BUY Strong Buy
+105.9% avg upside
11 analysts
$6.00
17.70% Upside
 -8.9%
MDXG
MiMedx Group
 Jul 06, 2026 BUY Strong Buy
+145.8% avg upside
17 analysts
$5.00
16.29% Upside
 +5.7%
CVRX
CVRx
 Jul 06, 2026 BUY Strong Buy
+135.8% avg upside
9 analysts
$14.00
185.11% Upside
 -6.4%
HYPR
Hyperfine
 Jul 01, 2026 BUY Strong Buy
+120.0% avg upside
7 analysts
$2.50
168.54% Upside
 -26.7%
AORT
Artivion
 Jun 29, 2026 BUY Strong Buy
+62.1% avg upside
8 analysts
$45.00
79.56% Upside
 +11.9%
TLSI
TriSalus Life Sciences
 Jun 25, 2026 BUY Strong Buy
+115.6% avg upside
8 analysts
$8.00
86.44% Upside
 -1.8%
BBNX
Beta Bionics, Inc.
 Jun 24, 2026 BUY Strong Buy
+23.2% avg upside
13 analysts
$20.00
15.73% Upside
 +17.4%
CLPT
ClearPoint Neuro
 Jun 23, 2026 BUY Strong Buy
+54.0% avg upside
7 analysts
$30.00
98.06% Upside
 -18.7%
NSPR
InspireMD
 Jun 11, 2026 BUY Strong Buy
+453.8% avg upside
8 analysts
$4.00
470.09% Upside
 -1.4%
NPCE
NeuroPace
 May 29, 2026 BUY Strong Buy
+9.1% avg upside
11 analysts
$20.00
24.48% Upside
 -2.0%
DXR
Daxor
 May 26, 2026 BUY Strong Buy
+98.8% avg upside
6 analysts
$23.00
111.00% Upside
 -0.5%
ADGM
Adagio Medical Holdings
 May 21, 2026 BUY Strong Buy
+560.4% avg upside
2 analysts
$4.00
654.75% Upside
 -37.3%
CLBT
Cellebrite DI
 May 15, 2026 BUY Buy
+25.6% avg upside
15 analysts
$21.00
35.91% Upside
 +18.9%
SMTI
Sanara MedTech
 May 13, 2026 BUY Strong Buy
+55.2% avg upside
5 analysts
$32.00
28.05% Upside
 +20.0%
TELA
TELA Bio
 May 13, 2026 BUY Strong Buy
+1131.2% avg upside
8 analysts
$2.00
173.56% Upside
 -23.8%
STXS
Stereotaxis
 May 13, 2026 BUY Strong Buy
+174.2% avg upside
7 analysts
$4.00
158.00% Upside
 -15.1%
LNSR
LENSAR
 May 11, 2026 BUY Strong Buy
+111.2% avg upside
4 analysts
$10.00
72.42% Upside
 -1.2%
TNDM
Tandem Diabetes Care
 May 08, 2026 BUY Strong Buy
+91.4% avg upside
29 analysts
$50.00
192.78% Upside
 +10.3%
LTRX
Lantronix
 May 07, 2026 BUY Strong Buy
+74.5% avg upside
9 analysts
$8.00
54.22% Upside
 -7.2%
KRMD
REPRO-MED Systems
 May 07, 2026 BUY Strong Buy
+56.6% avg upside
9 analysts
$8.00
94.64% Upside
 -4.5%
LMAT
Lemaitre Vascular
 May 06, 2026 BUY Strong Buy
-0.4% avg upside
15 analysts
$135.00
32.85% Upside
 -8.3%
LUNG
Pulmonx
 Apr 30, 2026 BUY Buy
+285.2% avg upside
9 analysts
$4.00
185.66% Upside
 +12.5%
AXGN
AxoGen
 Apr 28, 2026 BUY Strong Buy
-15.2% avg upside
21 analysts
$50.00
25.38% Upside
 -5.3%
SGHT
Sight Sciences
 Mar 30, 2026 BUY Strong Buy
+62.3% avg upside
13 analysts
$12.00
138.50% Upside
 +37.2%
IRMD
Iradimed
 Feb 11, 2026 BUY Strong Buy
-13.7% avg upside
6 analysts
$120.00
23.76% Upside
 -4.8%
NOTVQ
Inotiv
 Feb 10, 2026 BUY Strong Buy
+234134.2% avg upside
6 analysts
$1.50
13413.46% Upside
 -93.9%
AVR
Anteris Technologies Global Corp.
 Jan 23, 2026 BUY Strong Buy
+72.8% avg upside
5 analysts
$15.00
77.44% Upside
 +29.1%
COCH
Envoy Medical
 Oct 07, 2025 BUY Strong Buy
+812.2% avg upside
5 analysts
$6.00
755.24% Upside
 -54.5%
INSP
Inspire Medical Systems
 Aug 27, 2025 BUY Strong Buy
+62.3% avg upside
21 analysts
$150.00
196.46% Upside
 -45.2%
APYX
Apyx Medical
 Aug 09, 2024 BUY Strong Buy
+526.9% avg upside
11 analysts
$2.50
41.58% Downside
 +109.6%
FOCL
EDAP TMS
 Jul 22, 2024 BUY Buy
+51.8% avg upside
8 analysts
$10.00
84.03% Upside
 -69.6%
PAVM
PAVmed
 May 15, 2024 BUY Strong Buy
+588.6% avg upside
5 analysts
$4.00
32.54% Downside
 -66.8%
TSE:PRN
Profound Medical
 Nov 03, 2023 BUY Strong Buy
+96.0% avg upside
11 analysts
$19.64
104.62% Upside
 -21.2%
BIOLQ
BIOLASE
 May 31, 2023 BUY Strong Buy
+1197999900.0% avg upside
6 analysts
$40.00
3999999899.98% Upside
 ·
BTCY
Biotricity
 Feb 14, 2023 BUY Buy
+8322.0% avg upside
4 analysts
$12.00
10538.32% Upside
 ·
CATX
Perspective Therapeutics
 Sep 29, 2022 BUY Buy
+275.3% avg upside
22 analysts
$1.00
66.46% Downside
 +22.7%
OSUR
Orasure Technologies
 May 11, 2022 BUY Strong Buy
+119.6% avg upside
11 analysts
$10.00
158.45% Upside
 +43.8%
TSE:PINK
Perimeter Medical Imaging AI
 Apr 05, 2022 BUY Strong Buy
+726.2% avg upside
5 analysts
$5.61
1739.40% Upside
 -44.0%
UPHL
UpHealth
 Mar 31, 2022 HOLD Buy
+8049900.0% avg upside
6 analysts
$10.00
9999900.04% Upside
 ·
🔒 36 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Frank Takkinen — Frequently Asked Questions
How accurate are Frank Takkinen's stock ratings?
Based on the calls 13Foresight could measure, about 40% of Frank's ratings were profitable over a one-year hold, with an average return of -4.5% per rating, or -163.9% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Frank ranked on 13Foresight?
Frank Takkinen is currently ranked #149 with a 5-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Frank cover?
Frank most recently has ratings on ELUT, ANGO, RCEL, MDXG, CVRX, HYPR, AORT, TLSI, BBNX, CLPT, NSPR, NPCE and 29 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.